12 HR disopyramide 150 MG Extended Release Oral Capsule [Norpace]
- RxCUI
- 902652
- RxNorm name
- 12 HR disopyramide 150 MG Extended Release Oral Capsule [Norpace]
- Display name
- 12 HR disopyramide 150 MG Extended Release Oral Capsule [Norpace]
- Full name
- 12 HR disopyramide 150 MG Extended Release Oral Capsule [Norpace]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:25
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Norpace CR | DISOPYRAMIDE PHOSPHATE | Pfizer Laboratories Div Pfizer Inc | e2aa1642-d262-4520-bc6a-9fd3ad795677 | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | 902652 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e2aa1642-d262-4520-bc6a-9fd3ad795677 | 12 HR disopyramide 150 MG Extended Release Oral Capsule [Norpace] | SBD | 21 | Norpace ® disopyramide phosphate capsules Norpace ® CR disopyramide phosphate extended-release capsules | 20260318 |
| e2aa1642-d262-4520-bc6a-9fd3ad795677 | Norpace CR (as disopyramide phosphate) 150 MG 12 HR Extended Release Oral Capsule | SY | 21 | Norpace ® disopyramide phosphate capsules Norpace ® CR disopyramide phosphate extended-release capsules | 20260318 |
| e2aa1642-d262-4520-bc6a-9fd3ad795677 | Norpace CR 150 MG 12HR Extended Release Oral Capsule | PSN | 21 | Norpace ® disopyramide phosphate capsules Norpace ® CR disopyramide phosphate extended-release capsules | 20260318 |
| e2aa1642-d262-4520-bc6a-9fd3ad795677 | 12 HR Norpace 150 MG Extended Release Oral Capsule | SY | 21 | Norpace ® disopyramide phosphate capsules Norpace ® CR disopyramide phosphate extended-release capsules | 20260318 |